The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quantitative gene expression in primary and highest Gleason pattern cancer specimens identifies genes associated with clinical recurrence and prostate cancer–specific survival after radical prostatectomy.
E. A. Klein
Research Funding - Genomic Health
S. M. Falzarano
Research Funding - Genomic Health
T. Maddala
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
M. Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
R. J. Pelham
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
W. F. Novotny
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
S. Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
C. Magi-Galluzzi
Research Funding - Genomic Health